Renal denervation — The clues are in the kidney

Overview

Robert D. Simari, M.D., and Rajiv Gulati, M.D., Ph.D., discuss the data so far and the ongoing Symplicity-HTN3 trial. Will renal denervation move hypertension into the interventional cardiologists' domain?

Published

June 26, 2014

Created by

Related Videos

A multidisciplinary approach to genitourinary cancers

Mayo Clinic specialists describe considerations and advancements in surgical techniques used in the treatment of testicular cancer, bladder cancer and kidney cancer.

Surgical treatment options for people with prostate cancer

Igor Frank, M.D., discusses surgical treatment options for people with prostate cancer.

Mayo Clinic researchers help to shine new light on bladder cancer tumors

Mayo Clinic researchers help to shine new light on bladder cancer tumors.

Erectile dysfunction: Harbinger of heart disease?

Charanjit S. Rihal, M.D., and Stephen L. Kopecky, M.D., discuss erectile dysfunction and its impact on cardiovascular prognosis and diagnosis.

Mayo Clinic study suggests routine prostate size evaluation not as effective in cancer screening

If a man's PSA is quickly rising, he likely deserves a prostate biopsy to determine if he has prostate cancer. Assessment of change in prostate size should not influence the decision to biopsy. Dr. Rodney Breau discusses the study and ...

Medical Professional Video Center

Search Video Center

Renal denervation — The clues are in the kidney